ARCHIVES

Mason Asks For Better Technology Transfer In Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 18 No. 42 | October 30, 1992

Download PDF Visit The Full Archive

Related Articles

Vectibix Non-Inferior to Erbitux In Wild-Type Metastatic Disease

October 25, 2013

‘We Cannot Tolerate One Third Reduction In Centers. Prevention, Clinical Trials Programs’

September 20, 1991

Lynch Named Director, Yale Cancer Center

February 27, 2009

Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase

December 31, 2010

Nine New Grants Awarded In The NCI “Director’s Challenge”.

October 13, 2000

Tests Find No Conclusive Evidence On Two Chemicals

September 21, 1979